AKT1 and liver cancer: The inhibition of stearoyl-CoA desaturase (SCD), FASN and ACC, which provide FFAs within hepatocytes, abrogated Akt-driven HCC and reduced the hepatic cancer stem cells (CSC) pool [42,43].